• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异质性核糖核蛋白L以Akt激酶依赖性方式控制人乳头瘤病毒16型(HPV16)的RNA多聚腺苷酸化和剪接。

hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.

作者信息

Kajitani Naoko, Glahder Jacob, Wu Chengjun, Yu Haoran, Nilsson Kersti, Schwartz Stefan

机构信息

Department of Laboratory Medicine, Lund University, BMC-B13, 223 62 Lund, Sweden.

出版信息

Nucleic Acids Res. 2017 Sep 19;45(16):9654-9678. doi: 10.1093/nar/gkx606.

DOI:10.1093/nar/gkx606
PMID:28934469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5766200/
Abstract

Inhibition of the Akt kinase activates HPV16 late gene expression by reducing HPV16 early polyadenylation and by activating HPV16 late L1 mRNA splicing. We identified 'hot spots' for RNA binding proteins at the early polyA signal and at splice sites on HPV16 late mRNAs. We observed that hnRNP L was associated with sequences at all HPV16 late splice sites and at the early polyA signal. Akt kinase inhibition resulted in hnRNP L dephosphorylation and reduced association of hnRNP L with HPV16 mRNAs. This was accompanied by an increased binding of U2AF65 and Sam68 to HPV16 mRNAs. Furthermore, siRNA knock-down of hnRNP L or Akt induced HPV16 gene expression. Treatment of HPV16 immortalized keratinocytes with Akt kinase inhibitor reduced hnRNP L binding to HPV16 mRNAs and induced HPV16 L1 mRNA production. Finally, deletion of the hnRNP L binding sites in HPV16 subgenomic expression plasmids resulted in activation of HPV16 late gene expression. In conclusion, the Akt kinase inhibits HPV16 late gene expression at the level of RNA processing by controlling the RNA-binding protein hnRNP L. We speculate that Akt kinase activity upholds an intracellular milieu that favours HPV16 early gene expression and suppresses HPV16 late gene expression.

摘要

抑制Akt激酶可通过减少HPV16早期多聚腺苷酸化和激活HPV16晚期L1 mRNA剪接来激活HPV16晚期基因表达。我们在HPV16晚期mRNA的早期多聚A信号和剪接位点处鉴定了RNA结合蛋白的“热点”。我们观察到hnRNP L与所有HPV16晚期剪接位点和早期多聚A信号处的序列相关。Akt激酶抑制导致hnRNP L去磷酸化,并减少hnRNP L与HPV16 mRNA的结合。这伴随着U2AF65和Sam68与HPV16 mRNA结合的增加。此外,hnRNP L或Akt的siRNA敲低诱导了HPV16基因表达。用Akt激酶抑制剂处理HPV16永生化角质形成细胞可减少hnRNP L与HPV16 mRNA的结合,并诱导HPV16 L1 mRNA产生。最后,删除HPV16亚基因组表达质粒中的hnRNP L结合位点导致HPV16晚期基因表达激活。总之,Akt激酶通过控制RNA结合蛋白hnRNP L在RNA加工水平上抑制HPV16晚期基因表达。我们推测Akt激酶活性维持了一种有利于HPV16早期基因表达并抑制HPV16晚期基因表达的细胞内环境。

相似文献

1
hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.异质性核糖核蛋白L以Akt激酶依赖性方式控制人乳头瘤病毒16型(HPV16)的RNA多聚腺苷酸化和剪接。
Nucleic Acids Res. 2017 Sep 19;45(16):9654-9678. doi: 10.1093/nar/gkx606.
2
Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.hnRNP D 蛋白和 hnRNP A2/B1 与上游 AUAGUA RNA 基序结合抑制 HPV-16 晚期 L1 5′剪接位点 SD3632。
Nucleic Acids Res. 2013 Dec;41(22):10488-508. doi: 10.1093/nar/gkt803. Epub 2013 Sep 5.
3
Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.不均一核核糖核蛋白C蛋白与人乳头瘤病毒16型(HPV16)早期3'非翻译区相互作用,并减轻对HPV16晚期L1 mRNA剪接的抑制。
J Biol Chem. 2015 May 22;290(21):13354-71. doi: 10.1074/jbc.M115.638098. Epub 2015 Apr 15.
4
Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.异质核核糖核蛋白 A1(hnRNP A1)和 hnRNP A2 通过 E7 编码区中含 UAG 的序列抑制人乳头瘤病毒 16 剪接位点 SA409 的剪接。
J Virol. 2020 Sep 29;94(20). doi: 10.1128/JVI.01509-20.
5
The DNA damage response activates HPV16 late gene expression at the level of RNA processing.DNA 损伤反应通过 RNA 加工水平激活 HPV16 晚期基因表达。
Nucleic Acids Res. 2018 Jun 1;46(10):5029-5049. doi: 10.1093/nar/gky227.
6
hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs.hnRNP G/RBMX 通过新型剪接增强子增强 HPV16 E2 mRNA 的剪接,并抑制剪接 E7 致癌基因 mRNA 的产生。
Nucleic Acids Res. 2022 Apr 22;50(7):3867-3891. doi: 10.1093/nar/gkac213.
7
Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies.蛋白质组学鉴定异质性核糖核蛋白L作为SLM/Sam68核体的一种新成分。
BMC Cell Biol. 2009 Nov 13;10:82. doi: 10.1186/1471-2121-10-82.
8
Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.人乳头瘤病毒16型mRNA的剪接和聚腺苷酸化
Int J Mol Sci. 2017 Feb 9;18(2):366. doi: 10.3390/ijms18020366.
9
hnRNP U enhances caspase-9 splicing and is modulated by AKT-dependent phosphorylation of hnRNP L.hnRNP U 增强 caspase-9 的剪接,并受 hnRNP L 的 AKT 依赖性磷酸化调节。
J Biol Chem. 2013 Mar 22;288(12):8575-8584. doi: 10.1074/jbc.M112.443333. Epub 2013 Feb 8.
10
Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.聚嘧啶序列结合蛋白通过干扰主要晚期5'剪接位点SD3632处的剪接抑制元件来诱导人乳头瘤病毒16型晚期基因表达。
J Virol. 2008 Apr;82(7):3665-78. doi: 10.1128/JVI.02140-07. Epub 2008 Jan 23.

引用本文的文献

1
Ribosome profiling reveals that post-transcriptional control of Nalf1 by heterogeneous nuclear ribonucleoprotein L is required for paclitaxel-induced neuropathic pain.核糖体谱分析表明,异质性核糖核蛋白L对Nalf1的转录后调控是紫杉醇诱导的神经性疼痛所必需的。
Pain. 2025 Apr 2;166(9):2091-2102. doi: 10.1097/j.pain.0000000000003577.
2
Synchronous multiple primary cancers involving cervical cancer and follicular lymphoma: A case report.同步发生的涉及宫颈癌和滤泡性淋巴瘤的多原发性癌:一例报告。
Oncol Lett. 2025 Feb 13;29(4):183. doi: 10.3892/ol.2025.14930. eCollection 2025 Apr.
3
Alternative splicing in the genome of HPV and its regulation.

本文引用的文献

1
Carcinogenic human papillomavirus infection.致癌型人乳头瘤病毒感染。
Nat Rev Dis Primers. 2016 Dec 1;2:16086. doi: 10.1038/nrdp.2016.86.
2
Human papillomaviruses: research priorities for the next decade.人乳头瘤病毒:未来十年的研究重点
Trends Cancer. 2016 May;2(5):234-240. doi: 10.1016/j.trecan.2016.04.001.
3
Human Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.人乳头瘤病毒E2蛋白:连接复制、转录与RNA加工
HPV 基因组中的选择性剪接及其调控。
Front Cell Infect Microbiol. 2024 Oct 22;14:1443868. doi: 10.3389/fcimb.2024.1443868. eCollection 2024.
4
Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression.RNA 修饰蛋白的翻译后修饰在细胞动态和疾病进展中的作用。
Adv Sci (Weinh). 2024 Nov;11(44):e2406318. doi: 10.1002/advs.202406318. Epub 2024 Oct 8.
5
hnRNP H controls alternative splicing of human papillomavirus type 16 E1, E6, E7, and E6^E7 mRNAs via GGG motifs.hnRNP H 通过 GGG 基序控制人乳头瘤病毒 16 型 E1、E6、E7 和 E6^E7mRNA 的可变剪接。
J Virol. 2024 Oct 22;98(10):e0095124. doi: 10.1128/jvi.00951-24. Epub 2024 Sep 17.
6
HPV and RNA Binding Proteins: What We Know and What Remains to Be Discovered.HPV 和 RNA 结合蛋白:已知和待发现的内容。
Viruses. 2024 May 15;16(5):783. doi: 10.3390/v16050783.
7
A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization.一种新型 HPV16 剪接增强子,对病毒癌基因表达和细胞永生化至关重要。
Nucleic Acids Res. 2024 Jan 11;52(1):316-336. doi: 10.1093/nar/gkad1099.
8
Live and let die: signaling AKTivation and UPRegulation dynamics in SARS-CoVs infection and cancer.生死由天:SARS-CoV 感染和癌症中 AKT 激活和上调动力学的信号传导。
Cell Death Dis. 2022 Oct 3;13(10):846. doi: 10.1038/s41419-022-05250-5.
9
HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.HPV16 和 HPV18 基因组结构、表达和转录后调控。
Int J Mol Sci. 2022 Apr 29;23(9):4943. doi: 10.3390/ijms23094943.
10
hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs.hnRNP G/RBMX 通过新型剪接增强子增强 HPV16 E2 mRNA 的剪接,并抑制剪接 E7 致癌基因 mRNA 的产生。
Nucleic Acids Res. 2022 Apr 22;50(7):3867-3891. doi: 10.1093/nar/gkac213.
J Virol. 2016 Sep 12;90(19):8384-8. doi: 10.1128/JVI.00502-16. Print 2016 Oct 1.
4
Global analysis of physical and functional RNA targets of hnRNP L reveals distinct sequence and epigenetic features of repressed and enhanced exons.对异质性核糖核蛋白L的物理和功能RNA靶点进行全局分析,揭示了受抑制和增强外显子的不同序列和表观遗传特征。
RNA. 2015 Dec;21(12):2053-66. doi: 10.1261/rna.052969.115. Epub 2015 Oct 5.
5
Targeting CTCF to Control Virus Gene Expression: A Common Theme amongst Diverse DNA Viruses.靶向CTCF以控制病毒基因表达:多种DNA病毒的共同主题。
Viruses. 2015 Jul 6;7(7):3574-85. doi: 10.3390/v7072791.
6
RNA Binding Proteins that Control Human Papillomavirus Gene Expression.控制人乳头瘤病毒基因表达的RNA结合蛋白
Biomolecules. 2015 May 5;5(2):758-74. doi: 10.3390/biom5020758.
7
Acetylation of intragenic histones on HPV16 correlates with enhanced HPV16 gene expression.人乳头瘤病毒16型(HPV16)基因内组蛋白的乙酰化与HPV16基因表达增强相关。
Virology. 2015 Aug;482:244-59. doi: 10.1016/j.virol.2015.02.053. Epub 2015 Apr 17.
8
Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.不均一核核糖核蛋白C蛋白与人乳头瘤病毒16型(HPV16)早期3'非翻译区相互作用,并减轻对HPV16晚期L1 mRNA剪接的抑制。
J Biol Chem. 2015 May 22;290(21):13354-71. doi: 10.1074/jbc.M115.638098. Epub 2015 Apr 15.
9
hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.异质性核糖核蛋白L通过与其上游内含子相互作用来抑制CD44 V10外显子的剪接。
Biochim Biophys Acta. 2015 Jun;1849(6):743-50. doi: 10.1016/j.bbagrm.2015.01.004. Epub 2015 Jan 24.
10
Proteomics. Tissue-based map of the human proteome.蛋白质组学。人类蛋白质组组织图谱。
Science. 2015 Jan 23;347(6220):1260419. doi: 10.1126/science.1260419.